Vijaya Diagnostic Centre Ltd on Tuesday (November 3) reported a 37.4% year-on-year (YoY) increase in net profit to ₹59.5 crore for the second quarter, compared with ₹43.3 crore in the corresponding quarter last year.
Revenue increased 26.7% YoY to ₹255.4 crore from ₹201.6 crore in the year-ago period.
Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 37.8% to ₹112.7 crore from ₹81.8 crore. EBITDA margin expanded to 44.1% from 40.6% in the corresponding quarter last year, an improvement of 350 basis points.
ALSO READ | Diagnostics firms say top 50 laboratory health tests could become 30% cheaper
Suprita Reddy, MD and CEO, said, “I am pleased to share that we have sustained our strong growth momentum during Q2 FY27, delivering 26.7% year-on-year revenue growth, supported by 16.5% volume growth. Our existing centres grew by approximately 20%, while newer centres continued to ramp up well.
Our core markets maintained strong momentum, while Pune has been witnessing a meaningful turnaround with consistent double-digit growth since few quarters. We continue to see encouraging momentum in West Bengal, as our brand awareness strengthens.
We are particularly pleased with the response in Tier-II markets such as Krishnanagar and Diamond Harbour. On the expansion front, we have commissioned 2 hubs and 7 spokes so far during FY27. Looking ahead, we expect to commission another 3 hubs & 7 spokes in H2 FY27, followed by 3 additional hubs in Q1 FY28, further strengthening our network and expanding our presence across key markets.
ALSO READ | Vijaya Diagnostics Q1 Results: Stock jumps after 20% revenue growth, margins maintained
During the quarter, we entered into a Business Transfer Agreement to acquire Arya Wellness Centre in Guwahati, Assam. This marks our entry into the North-East region and is an important step towards expanding our geographical presence beyond our existing markets.
We believe this acquisition provides us with a strong platform to establish our presence in Guwahati and gradually explore further growth opportunities across the North-East, leveraging our expertise in integrated diagnostics and operational excellence. We remain committed to strengthening our presence across key markets, investing in advanced technology and delivering high-quality diagnostic services to support sustainable long-term growth.”
Shares of Vijaya Diagnostic Centre Ltd ended at ₹1,443.95, down by ₹13.80, or 0.95%, on the BSE.
ALSO READ | Vijaya Diagnostic Centre IPO subscribed 30% on day 1